RPL30
Gene Information
- Official Symbol: RPL30
- Official Name: ribosomal protein L30
- Aliases and Previous Symbols: N/A
- Entrez ID: 6156
- UniProt: P62888
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: N/A
Pfam Domains GO Terms
Pfam Domains
| Ribosomal L7Ae |
GO Terms
| polysomal ribosome |
| killing of cells of other organism |
| disruption of cells of other organism |
| antimicrobial humoral immune response mediated by antimicrobial peptide |
| cytosolic large ribosomal subunit |
| cytoplasmic translation |
| defense response to Gram-negative bacterium |
| cell killing |
| SRP-dependent cotranslational protein targeting to membrane |
| cotranslational protein targeting to membrane |
| protein targeting to ER |
| antimicrobial humoral response |
| establishment of protein localization to endoplasmic reticulum |
| viral transcription |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| viral gene expression |
| protein localization to endoplasmic reticulum |
| translational initiation |
| modification of morphology or physiology of other organism |
| protein targeting to membrane |
| structural constituent of ribosome |
| nuclear-transcribed mRNA catabolic process |
| mRNA catabolic process |
| RNA catabolic process |
| postsynaptic density |
| establishment of protein localization to membrane |
| defense response to bacterium |
| humoral immune response |
| protein targeting |
| nucleobase-containing compound catabolic process |
| translation |
| peptide biosynthetic process |
| focal adhesion |
| establishment of protein localization to organelle |
| heterocycle catabolic process |
| cellular nitrogen compound catabolic process |
| aromatic compound catabolic process |
| protein localization to membrane |
| organic cyclic compound catabolic process |
| amide biosynthetic process |
| peptide metabolic process |
| response to bacterium |
| mRNA metabolic process |
| viral process |
| protein localization to organelle |
| symbiotic process |
| cellular amide metabolic process |
| interspecies interaction between organisms |
| cellular macromolecule catabolic process |
| defense response to other organism |
| intracellular protein transport |
| macromolecule catabolic process |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| defense response |
| RNA binding |
| organonitrogen compound biosynthetic process |
| protein transport |
| intracellular transport |
| peptide transport |
| amide transport |
| cellular protein localization |
| cellular macromolecule localization |
| establishment of protein localization |
| cellular nitrogen compound biosynthetic process |
| RNA metabolic process |
| cellular macromolecule biosynthetic process |
| negative regulation of gene expression |
| macromolecule biosynthetic process |
| organic substance catabolic process |
| cellular catabolic process |
| establishment of localization in cell |
| nitrogen compound transport |
| immune response |
| membrane |
| gene expression |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| GOLGA6L1 | 0.526 |
| TCEB3C | 0.522 |
| TCEB3CL2 | 0.51 |
| TCEB3CL | 0.499 |
| HGC6.3 | 0.499 |
| CACNA1A | 0.498 |
| PSMB4 | 0.487 |
| ORC1 | 0.487 |
| ZFAND5 | 0.486 |
| RPS12 | 0.485 |
| DISP2 | 0.485 |
| RPL34 | 0.482 |
| CHD4 | 0.475 |
| PSMC2 | 0.474 |
| NARFL | 0.472 |
| RPS28 | 0.47 |
| RPL6 | 0.469 |
| RANBP2 | 0.466 |
| VASN | 0.465 |
| TTC31 | 0.458 |
| COPG1 | 0.456 |
| POLA1 | 0.454 |
| TBC1D3G | 0.453 |
| RAD51 | 0.452 |
| TBC1D3F | 0.45 |
| TBC1D3I | 0.447 |
| C1QTNF9B | 0.447 |
| TBC1D3E | 0.446 |
| TBC1D3K | 0.446 |
| TBC1D3L | 0.446 |
| HIST1H2BE | 0.445 |
| CLN6 | 0.444 |
| RPL9 | 0.444 |
| NAPA | 0.443 |
| TBC1D3H | 0.441 |
| RBBP5 | 0.438 |
| GOSR2 | 0.436 |
| SUPT6H | 0.435 |
| SMG7 | 0.434 |
| FAM25B | 0.433 |
| RPL17 | 0.432 |
| FAM160A1 | 0.431 |
| RPS14 | 0.43 |
| COPB1 | 0.43 |
| ATP6V1B2 | 0.427 |
| RPS19 | 0.427 |
| PSMD11 | 0.425 |
| TICRR | 0.425 |
| DDX56 | 0.425 |
| RPS5 | 0.424 |
| ATP6V1A | 0.423 |
| SH3BP1 | 0.423 |
| MT1E | 0.423 |
| CACTIN | 0.422 |
| TBC1D3C | 0.421 |
| TERF2 | 0.421 |
| RRN3 | 0.421 |
| TOP1MT | 0.42 |
| ATP6V1C1 | 0.419 |
| DDTL | 0.419 |
| ARCN1 | 0.419 |
| PAN3 | 0.418 |
| RPS6 | 0.418 |
| NSF | 0.417 |
| VPS28 | 0.416 |
| AATF | 0.416 |
| TRAIP | 0.416 |
| MYB | 0.416 |
| PSMD3 | 0.415 |
| NUP153 | 0.415 |
| PSMD1 | 0.414 |
| PSMA7 | 0.414 |
| RFFL | 0.414 |
| MYO1H | 0.414 |
| AQR | 0.413 |
| NUMA1 | 0.413 |
| HAP1 | 0.413 |
| RPLP1 | 0.413 |
| EXOSC9 | 0.412 |
| NOL12 | 0.412 |
| EXOSC3 | 0.412 |
| USP37 | 0.412 |
| TBC1D3 | 0.41 |
| SMG1 | 0.41 |
| NOP16 | 0.41 |
| HIVEP3 | 0.409 |
| KIAA0947 | 0.408 |
| EXOSC5 | 0.407 |
| KIF3C | 0.407 |
| CHAF1A | 0.407 |
| EIF3K | 0.407 |
| CGB2 | 0.406 |
| SLC6A17 | 0.406 |
| UTP3 | 0.406 |
| CBWD5 | 0.406 |
| CDC45 | 0.406 |
| ZNF106 | 0.405 |
| C14orf93 | 0.405 |
| BRD2 | 0.405 |
| ATP1A3 | 0.404 |
| RPL14 | 0.404 |
| PSMA6 | 0.404 |
| SNX15 | 0.403 |
| CTAGE9 | 0.403 |
| ISCU | 0.403 |
| RFPL3 | 0.402 |
| CEP192 | 0.402 |
| RPS2 | 0.402 |
| RRP15 | 0.402 |
| RRP1 | 0.401 |
| CBWD3 | 0.4 |
| ANKLE1 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 34/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 2/28 |
| blood | 0/28 |
| bone | 2/26 |
| breast | 2/33 |
| central nervous system | 1/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 1/13 |
| fibroblast | 0/1 |
| gastric | 1/16 |
| kidney | 3/21 |
| liver | 0/20 |
| lung | 4/75 |
| lymphocyte | 1/16 |
| ovary | 1/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 2/15 |
| prostate | 0/1 |
| skin | 2/24 |
| soft tissue | 1/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 1/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 480
- Expression level (log2 read counts): 8.43
Expression Distribution
RPL30 Expression in NALM6 Cells: 8.43